한글목차

인터벤션 이미징 세계 시장 규모는 2024년 238억 7,000만 달러로 평가되었고, 2030년까지 연평균 5.35%의 안정적인 성장이 예상됩니다.

인터벤션 이미징은 정확도를 높이고 환자 결과를 크게 개선하는 실시간 영상 유도 시술을 가능하게 함으로써 의료 분야를 혁신적으로 변화시켰습니다. 이러한 첨단 기술은 복잡한 수술부터 최소 침습적 시술에 이르기까지 의료 전문가들이 다양한 증상을 진단하고 치료하는 방법을 재정의하고 있습니다. 예를 들어, 2021년 10월 PubMed Central이 발표한 연구에 따르면, 팬데믹이 전 세계 방사선과 서비스 제공에 큰 영향을 미쳤다는 사실이 강조되었습니다. 시장은 초기에는 봉쇄 조치로 인해 혼란을 겪었지만, 규제 완화로 인해 예측 기간 동안 안정적인 성장이 예상됩니다. 이러한 성장에는 여러 가지 요인이 기여하고 있는데, 그 중 하나는 전 세계 암 발병률 증가로 인해 인터벤션 이미징 솔루션에 대한 수요가 증가하고 있다는 점입니다. 이러한 기술은 종양의 시각화 및 정밀한 표적화 등 정확한 진단 및 치료 개입을 가능하게 하여 궁극적으로 생존율을 향상시킬 수 있습니다. 미국암협회에 따르면, 2022년 미국에서 190만 명의 암 환자가 새로 발생하고 60만 9360명이 암으로 사망할 것으로 예상되며, CT 스캐너 및 MRI 시스템과 같은 인터벤션 이미징에 대한 수요 증가는 특히 생활수준이 높은 국가에서 고급 진단 절차에 대한 접근성을 향상시키는 데 도움이 될 것으로 예상됩니다. 진단 절차에 대한 접근성이 강화된 것이 주요 원인으로 분석됩니다.

시장 성장 촉진요인

심혈관 및 신경혈관 중재술 증가

주요 시장 과제:

감염 관리에 대한 우려

주요 시장 동향 :

주요 시장 동향 : 환자 안전과 방사선량 감소에 초점을 맞추고 있다:

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 인터벤션 이미징 시장에 미치는 영향

제5장 세계의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제공 제품별(CT 스캐너, X선 시스템, MRI 시스템, 초음파 영상 진단 시스템, 기타)
  • 용도별(심장병학, 신경학, 근골격학, 종양학, 비뇨기과, 소화기학, 산과, 부인과, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 아시아태평양의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제7장 유럽의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제8장 북미의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제9장 남미의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 인터벤션 이미징 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제13장 세계의 인터벤션 이미징 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 PESTEL 분석

제16장 가격 분석

제17장 경쟁 구도

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

제18장 전략적 제안

제19장 리서치사에 대해 & 면책사항

영문목차

The global Interventional Imaging Market was valued at USD 23.87 billion in 2024 and is projected to experience steady growth at a compound annual growth rate (CAGR) of 5.35% through 2030. Interventional imaging has transformed the medical field by enabling real-time, image-guided procedures that enhance precision and significantly improve patient outcomes. These advanced techniques have redefined how medical professionals diagnose and treat a variety of conditions, ranging from complex surgeries to minimally invasive procedures. For instance, a study published by PubMed Central in October 2021 highlighted the pandemic's significant impact on service delivery in radiology departments worldwide. While the market faced initial disruptions due to lockdown measures, the easing of restrictions is expected to drive stable growth during the forecast period. This growth is fueled by several factors, including the increasing global incidence of cancer, which has escalated the demand for interventional imaging solutions. These technologies enable precise diagnostic and therapeutic interventions, such as visualizing tumors and targeting them with high accuracy, ultimately improving survival rates. According to the American Cancer Society, it was projected that 1.9 million new cancer cases and 609,360 cancer-related deaths would occur in the U.S. in 2022. The growing demand for interventional imaging, such as CT scanners and MRI systems, is largely attributed to enhanced access to advanced diagnostic procedures, particularly in countries with higher living standards.

Key Market Drivers:

Increase in Cardiovascular and Neurovascular Interventions:

Cardiovascular diseases (CVDs) remain the leading cause of death globally, with an estimated 17.9 million fatalities in 2019, representing 32% of all global deaths, according to the World Health Organization. This alarming trend underscores the pressing need for effective solutions in cardiovascular medicine. The use of artificial intelligence (AI) in diagnostic and interventional radiology has gained momentum, enhancing image analysis, supporting accurate diagnoses, and assisting with intervention recommendations. Minimally invasive cardiovascular interventions have gained widespread acceptance due to their advantages over traditional open surgery, such as reduced risk, quicker recovery times, and improved patient outcomes. Interventional imaging technologies play a crucial role in these procedures by providing real-time, high-resolution imaging to guide healthcare professionals during diagnosis, treatment planning, and interventions, ensuring optimal patient care.

Key Market Challenges:

Concerns Over Infection Control:

Healthcare-associated infections (HAIs) are a significant risk to patients, and interventional radiology is no exception. The use of imaging equipment across multiple patients increases the potential for cross-contamination if infection prevention and control (IPC) protocols are not strictly followed. Radiology departments must now adhere to rigorous IPC measures, including the thorough disinfection of equipment, proper hand hygiene, and the use of personal protective equipment (PPE). Despite these efforts, infection control remains a challenge, necessitating the adoption of advanced technologies such as antimicrobial coatings, air filtration systems, and innovative sterilization methods. These infection control concerns may drive up operational costs for healthcare facilities as they invest in enhanced IPC practices, staff training, and the use of disposable or easily sterilized equipment.

Key Market Trends:

Focus on Patient Safety and Radiation Dose Reduction:

Patient safety is a top priority in interventional imaging procedures, which, although minimally invasive, carry potential risks such as radiation exposure, complications from contrast agents, and procedural issues. There has been a notable shift towards enhancing patient safety through improved medical personnel training, the development of comprehensive safety protocols, and the integration of technological advancements to reduce risks. Radiation exposure, in particular, is a key concern, as ionizing radiation can cause tissue damage and increase the risk of cancer. To mitigate this, there has been a concerted effort to reduce radiation doses in interventional imaging through advancements in technology, procedural adjustments, and the implementation of better radiation safety protocols. For example, many newly developed imaging systems feature automatic radiation dose adjustment, ensuring that only the minimum required dose is applied. The ongoing focus on patient safety and radiation dose reduction has spurred innovation, encouraging manufacturers to invest heavily in research and development to create safer and more efficient imaging solutions.

Key Market Players:

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

Report Scope:

This report segments the Global Interventional Imaging Market into the following categories, along with detailed industry trends:

By Offering:

• CT Scanners
• X-Ray Systems
• MRI Systems
• Ultrasound Imaging Systems
• Other Imaging Solutions

By Application:

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Other Applications

By Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape:

This section provides detailed analysis and profiles of the leading companies in the global Interventional Imaging Market.

Available Customizations:

TechSci Research offers customization options for this market report tailored to a company's specific needs. Customization options include detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Applications
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Interventional Imaging Market

5. Global Interventional Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others)
  • 5.2.2. By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Interventional Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Offering
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Interventional Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Offering
      • 6.3.1.2.2. By Application
  • 6.3.2. India Interventional Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Offering
      • 6.3.2.2.2. By Application
  • 6.3.3. Australia Interventional Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Offering
      • 6.3.3.2.2. By Application
  • 6.3.4. Japan Interventional Imaging Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Offering
      • 6.3.4.2.2. By Application
  • 6.3.5. South Korea Interventional Imaging Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Offering
      • 6.3.5.2.2. By Application

7. Europe Interventional Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Offering
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Interventional Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Offering
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Interventional Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Offering
      • 7.3.2.2.2. By Application
  • 7.3.3. Spain Interventional Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Offering
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Interventional Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Offering
      • 7.3.4.2.2. By Application
  • 7.3.5. United Kingdom Interventional Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Offering
      • 7.3.5.2.2. By Application

8. North America Interventional Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Offering
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Interventional Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Offering
      • 8.3.1.2.2. By Application
  • 8.3.2. Mexico Interventional Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Offering
      • 8.3.2.2.2. By Application
  • 8.3.3. Canada Interventional Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Offering
      • 8.3.3.2.2. By Application

9. South America Interventional Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Offering
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Interventional Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Offering
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Interventional Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Offering
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Interventional Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Offering
      • 9.3.3.2.2. By Application

10. Middle East and Africa Interventional Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Offering
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Interventional Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Offering
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Interventional Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Offering
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Interventional Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Offering
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Interventional Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Pricing Analysis

17. Competitive Landscape

• 17.1. Becton, Dickinson and Company
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (As Reported)
  • 17.1.5. Recent Developments
• 17.2. Canon Inc.
• 17.3. Esaote SpA
• 17.4. FUJIFILM Holdings Corporation
• 17.5. Hologic, Inc.
• 17.6. Intuitive Surgical, Inc.
• 17.7. Koninklijke Philips NV
• 17.8. Medtronic plc
• 17.9. Siemens Healthineers AG
• 17.10. Stryker Corporation

18. Strategic Recommendations

19. About Us & Disclaimer